Genetic variations in insulin signaling, such as the ENPP1 Lys121Gln and IRS1 Gly972Arg polymorphisms, are associated with NAFLD pathogenesis, adding complexity to the condition. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.